Valuation Ipca Laboratories Limited Bombay S.E.

Stocks

Market Closed - Bombay S.E. 06:02:28 2026-09-22 EDT			5-day change	1st Jan Change
1,992.20 ^INR	-0.79%		+1.15%	+39.90%

08-14	Ipca Laboratories Limited, Q1 2027 Earnings Call, Aug 14, 2026
08-13	Ipca Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	270,385	205,589	313,934	381,038	406,231	505,480	-	-
Change	-	-23.96%	52.7%	21.38%	6.61%	24.43%	-	-
Enterprise Value (EV) ¹	275,070	201,870	325,349	391,231	408,673	494,830	485,524	473,337
Change	-	-26.61%	61.17%	20.25%	4.46%	21.08%	-1.88%	-2.51%
P/E	30.6x	43.6x	57.4x	51.6x	35.6x	33.3x	28.5x	24.9x
PBR	4.92x	2.58x	4.96x	5.48x	5.04x	5.3x	4.57x	3.9x
PEG	-	-0.9x	3.6x	1.5x	0.7x	1x	1.7x	1.7x
Capitalization / Revenue	4.64x	3.29x	4.07x	4.26x	4.21x	4.6x	4.12x	3.72x
EV / Revenue	4.72x	3.23x	4.22x	4.38x	4.24x	4.5x	3.96x	3.48x
EV / EBITDA	21x	21.8x	24.6x	22.7x	20.7x	19.6x	16.6x	14.3x
EV / EBIT	25.6x	30.3x	33.8x	29.5x	26.2x	24x	20.6x	17.4x
EV / FCF	72.9x	64.8x	60.9x	71.7x	83.5x	63.2x	40.2x	30.2x
FCF Yield	1.37%	1.54%	1.64%	1.4%	1.2%	1.58%	2.49%	3.32%
Dividend per Share ²	8	4	4	2	6	5.769	6.185	7.114
Rate of return	0.75%	0.49%	0.32%	0.13%	0.37%	0.29%	0.31%	0.36%
EPS ²	34.85	18.58	21.57	29.08	44.98	59.87	69.92	80.13
Distribution rate	23%	21.5%	18.5%	6.88%	13.3%	9.64%	8.84%	8.88%
Net sales ¹	58,298	62,443	77,050	89,396	96,463	109,955	122,660	136,008
EBITDA ¹	13,073	9,268	13,212	17,261	19,786	25,244	29,171	33,139
EBIT ¹	10,748	6,652	9,639	13,283	15,604	20,577	23,583	27,169
Net income ¹	8,841	4,713	5,474	7,377	11,411	15,145	17,797	20,425
Net Debt ¹	4,685	-3,720	11,415	10,193	2,442	-10,650	-19,956	-32,144
Reference price ²	1,065.75	810.35	1,237.40	1,501.90	1,601.20	1,992.40	1,992.40	1,992.40
Nbr of stocks (in thousands)	253,704	253,704	253,704	253,704	253,704	253,704	-	-
Announcement Date	5/24/22	5/29/23	5/29/24	5/29/25	5/29/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.12x	12.04x	24.4x	0.6%	1,038B
JOHNSON & JOHNSON	29.97x	6.67x	18.66x	1.99%	649B
ABBVIE INC.	33.44x	7.83x	16.17x	2.59%	467B
ROCHE HOLDING AG	19.76x	4.83x	11.96x	2.74%	355B
NOVARTIS AG	19.95x	5.21x	12.92x	3.08%	269B
ASTRAZENECA PLC	21.41x	4.44x	12.62x	1.99%	260B
AMGEN INC.	24.9x	6.52x	11.62x	2.57%	213B
NOVO NORDISK A/S	11.64x	4.24x	8.76x	4.32%	176B
GILEAD SCIENCES, INC.	-45.54x	6.63x	25.88x	2.19%	187B
Average	16.52x	6.49x	15.89x	2.45%	401.68B
Weighted average by Cap.	23.87x	7.78x	17.95x	1.98%